rs267608436
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP5BS2
This summary comes from the ClinGen Evidence Repository: The p.Arg65Gln variant in CDKL5 is present in 2 female and 1 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg65Gln variant is observed in at least 2 unaffected individuals (internal database) (BS2). The p.Arg65Gln variant is found in 2 patients with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Arg65Gln variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA170462/MONDO:0100039/034
Frequency
Consequence
NM_001323289.2 missense
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKL5 | NM_001323289.2 | c.194G>A | p.Arg65Gln | missense_variant | Exon 5 of 18 | ENST00000623535.2 | NP_001310218.1 | |
| CDKL5 | NM_001037343.2 | c.194G>A | p.Arg65Gln | missense_variant | Exon 6 of 22 | NP_001032420.1 | ||
| CDKL5 | NM_003159.3 | c.194G>A | p.Arg65Gln | missense_variant | Exon 5 of 21 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111779Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000164 AC: 3AN: 182997 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000165 AC: 18AN: 1093207Hom.: 0 Cov.: 28 AF XY: 0.0000223 AC XY: 8AN XY: 358913 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111779Hom.: 0 Cov.: 23 AF XY: 0.0000294 AC XY: 1AN XY: 34005 show subpopulations
ClinVar
Submissions by phenotype
CDKL5 disorder Benign:2
The p.Arg65Gln variant in CDKL5 is present in 2 female and 1 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg65Gln variant is observed in at least 2 unaffected individuals (internal database) (BS2). The p.Arg65Gln variant is found in 2 patients with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Arg65Gln variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP5). -
This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in population databases (gnomAD , Turkish Variome) is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of CDKL5 disorder (BS2). PubMed: 17993579 Variation ID: 143789 -
not specified Benign:1
Reported in paper as c.193C>A, but chromatogram shows c.194G>A; found in unaffected male family member; however, In silico prediction: SIFT = deleterious, MutationTaster = disease-causing, PolyPhen2 = probably damaging, AlignGVGD = pathogenic (C35) -
not provided Benign:1
This variant is associated with the following publications: (PMID: 17993579) -
CDKL5-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at